TrialClinical genitourinary cancer2023

Results From a Randomized Phase II Trial of Sunitinib and Gemcitabine or Sunitinib in Advanced Renal Cell Carcinoma with Sarcomatoid Features: ECOG-ACRIN E1808.

Bradley C Carthon et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.